December 11, 2018
UNC Lineberger's Hazel Nichols, PhD, and collaborators from the Premenopausal Breast Cancer Collaborative Group identified elevated breast cancer risk after childbirth in women younger than 55.
December 11, 2018
December 11, 2018
December 11, 2018
December 11, 2018
December 11, 2018
December 7, 2018
The Carolina Breast Cancer Study, UNC Lineberger’s landmark population-based study of breast cancer risk, biology, and outcomes that focuses on young and African-American women in North Carolina, recently celebrated the 10-year anniversary of its third phase. The study’s leadership hosted events this fall in Concord, Greenville and Cary to bring together and recognize the contributions of …
December 4, 2018
UNC Lineberger's Ethan Basch, MD, MSc, professor in the UNC School of Medicine Division of Hematology/Oncology and director of the UNC Lineberger's Cancer Outcomes Research Program, was a contributor to a white paper for the Friends of Cancer Research. Basch and the working group behind the paper developed a working definition of "tolerability" to better capture the patient experience.
December 3, 2018
The University of North Carolina System recently awarded UNC Lineberger’s Andrew Wang, MD, and Jonathan Serody, MD, a four year, $2.09 million Research Opportunities Initiative grant to support their research using pharmacoengineering approaches to develop more effective personalized cancer vaccines. The grant was one of 15 awarded to scientists across the UNC System, with the specific intent to support …
December 3, 2018
At the 60th American Society of Hematology Annual Meeting in San Diego on Monday, UNC Lineberger's Natalie Grover, MD, presented preliminary results from a clinical study of an investigational cellular immunotherapy for Hodgkin lymphoma and non-Hodgkin lymphoma expressing the CD30 protein marker.
